Surgical Innovations Group plc
SUN.L · LSE
12/31/2024 | 12/31/2023 | 12/31/2022 | 12/31/2021 | |
|---|---|---|---|---|
| Revenue | £11,945 | £12,014 | £11,340 | £9,126 |
| % Growth | -0.6% | 5.9% | 24.3% | – |
| Cost of Goods Sold | £8,509 | £8,566 | £7,418 | £5,995 |
| Gross Profit | £3,436 | £3,448 | £3,922 | £3,131 |
| % Margin | 28.8% | 28.7% | 34.6% | 34.3% |
| R&D Expenses | £1,149 | £1,099 | £1,164 | £973 |
| G&A Expenses | £1,138 | £869 | £745 | £797 |
| SG&A Expenses | £2,711 | £2,628 | £2,418 | £2,128 |
| Sales & Mktg Exp. | £1,573 | £1,759 | £1,673 | £1,331 |
| Other Operating Expenses | £367 | £317 | £299 | £510 |
| Operating Expenses | £4,227 | £4,044 | £3,881 | £3,611 |
| Operating Income | -£791 | -£596 | £41 | -£480 |
| % Margin | -6.6% | -5% | 0.4% | -5.3% |
| Other Income/Exp. Net | -£1,259 | -£132 | -£98 | -£130 |
| Pre-Tax Income | -£2,050 | -£728 | -£57 | -£585 |
| Tax Expense | -£107 | -£219 | -£321 | -£129 |
| Net Income | -£1,943 | -£509 | £264 | -£456 |
| % Margin | -16.3% | -4.2% | 2.3% | -5% |
| EPS | -0.002 | -0.001 | 0 | -0.001 |
| % Growth | -320% | -266.7% | 160% | – |
| EPS Diluted | -0.002 | -0.001 | 0 | -0.001 |
| Weighted Avg Shares Out | 932,816 | 932,816 | 932,816 | 936,564 |
| Weighted Avg Shares Out Dil | 932,816 | 932,816 | 935,946 | 936,564 |
| Supplemental Information | – | – | – | – |
| Interest Income | £0 | £0 | £0 | £0 |
| Interest Expense | £99 | £132 | £98 | £130 |
| Depreciation & Amortization | £1,852 | £757 | £587 | £702 |
| EBITDA | -£99 | £161 | £628 | £247 |
| % Margin | -0.8% | 1.3% | 5.5% | 2.7% |